Report of Foreign Issuer (6-k)
May 17 2019 - 6:07AM
Edgar (US Regulatory)
Securities and Exchange Commission
Washington, D.C. 20549
Form
6-K
Report of
Foreign Issuer
Pursuant to Rule
13a-16
or 15d/16 of
the Securities Exchange Act of 1934
May 2019
Aegon N.V.
Aegonplein 50
2591 TV
THE HAGUE
The Netherlands
Aegons press release, dated May 17, 2019, is included as appendix and incorporated herein by
reference.
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Aegon N.V.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
|
Date: May 17, 2019
|
|
|
|
By
|
|
/s/ J.O. van Klinken
|
|
|
|
|
|
|
J.O. van Klinken
|
|
|
|
|
|
|
Executive Vice President and General Counsel
|
Aegon to divest stake in partnership with Sony Life in Japan
Aegon announces an agreement to sell its 50% stake in the variable annuity joint ventures in Japan for total cash proceeds of approximately EUR 130 million
(JPY 16 billion) to its partner Sony Life.
With the evolving market conditions, we mutually agreed that the future of the variable annuity
business in Japan is best served as a wholly-owned part of our longstanding partner Sony Life, said Alex Wynaendts, CEO of Aegon. I am confident that this change is in the best interest of all stakeholders. This divestment allows Aegon
to fully focus on its most promising businesses in Asia serving the fastest growing customer segments and offering the most significant opportunities.
The divestment is consistent with the companys strategy to focus on driving profitable sales growth and sustainably growing capital generation. The
divestment will not have a material impact on Aegons capital position and is expected to lead to an IFRS gain of approximately EUR 50 million, to be reported in Other income at time of closing. Upon completion of the
transaction, the cash proceeds will be upstreamed to the group.
The details of the divestment are currently being finalized and will be subject to normal
regulatory approvals for transactions of this nature. This is likely to be completed by the end of 2019. To facilitate the transition, Aegon will continue to support the operations with certain hedging, consulting and administrative activities
during a transition period. An update will be provided once the full transaction agreements are signed.
Aegon will remain focused and committed to the
fast-growing customer segments in Asia. Core products in the region include universal life insurance and protection products. Universal life insurance products are primarily offered through the High Net Worth segment via Transamerica Life Bermuda,
which continues to expand geographically. Protection products are sold via
direct-to-consumer
channels and digital distribution platforms in the joint ventures, such as
in China, where Aegon is committed to a protection led strategy focused on critical illness and whole life products enabling the joint venture to grow sales in the last five years. Aegon also invests in digital distribution platforms in other Asian
markets to expand distribution capabilities. Furthermore, the successful Chinese asset manager joint venture, Aegon Industrial Fund Management Company, is a cornerstone of the growth strategy of Aegon Asset Management.
About Aegon
Aegons roots go back 175 years
to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the worlds leading financial services
organizations, providing life insurance, pensions and asset management. Aegons purpose is to help people achieve a lifetime of financial security. More information on aegon.com.
|
|
|
Contacts
|
|
|
Media relations
|
|
Investor relations
|
Dick Schiethart
|
|
Jan Willem Weidema
|
|
|
+31(0) 70 344 8821
|
|
+31(0) 70 344 8028
|
dick.schiethart@aegon.com
|
|
janwillem.weidema@aegon.com
|
Disclaimers
Forward-looking statements
The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these
forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties.
Such risks and uncertainties include but are not limited to the following:
|
|
|
Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands
and the United Kingdom;
|
|
|
|
Changes in the performance of financial markets, including emerging markets, such as with regard to:
|
|
|
|
The frequency and severity of defaults by issuers in Aegons fixed income investment portfolios;
|
|
|
|
The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting
decline in the value of equity and debt securities Aegon holds; and
|
|
|
|
The effects of declining creditworthiness of certain public sector securities and the resulting decline in the
value of government exposure that Aegon holds;
|
|
|
|
Changes in the performance of Aegons investment portfolio and decline in ratings of Aegons
counterparties;
|
|
|
|
Consequences of an actual or potential
break-up
of the European monetary
union in whole or in part;
|
|
|
|
Consequences of the anticipated exit of the United Kingdom from the European Union and potential consequences of
other European Union countries leaving the European Union;
|
|
|
|
The frequency and severity of insured loss events;
|
|
|
|
Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the
profitability of Aegons insurance products;
|
|
|
|
Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;
|
|
|
|
Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
|
|
|
|
Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
|
|
|
|
Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets
funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;
|
|
|
|
Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
|
|
|
|
Changes in laws and regulations, particularly those affecting Aegons operations ability to hire and
retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers;
|
|
|
|
Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which
Aegon operates;
|
|
|
|
Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and
the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the
designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer
(G-SII);
|
|
|
|
Changes in customer behavior and public opinion in general related to, among other things, the type of products
Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;
|
|
|
|
Acts of God, acts of terrorism, acts of war and pandemics;
|
|
|
|
Changes in the policies of central banks and/or governments;
|
|
|
|
Lowering of one or more of Aegons debt ratings issued by recognized rating organizations and the adverse
impact such action may have on Aegons ability to raise capital and on its liquidity and financial condition;
|
|
|
|
Lowering of one or more of insurer financial strength ratings of Aegons insurance subsidiaries and the
adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;
|
|
|
|
The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions
affecting the capital Aegon is required to maintain;
|
|
|
|
Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does
business;
|
|
|
|
As Aegons operations support complex transactions and are highly dependent on the proper functioning of
information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate
controls including with respect to third parties with which we do business may disrupt Aegons business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;
|
|
|
|
Customer responsiveness to both new products and distribution channels;
|
|
|
|
Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for
Aegons products;
|
|
|
|
Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies,
voluntarily or otherwise, which may affect Aegons reported results, shareholders equity or regulatory capital adequacy levels;
|
|
|
|
Aegons projected results are highly sensitive to complex mathematical models of financial markets,
mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future
performance will vary from projected results;
|
|
|
|
The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items,
including Aegons ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;
|
|
|
|
Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt
Aegons business; and
|
|
|
|
Aegons failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost
saving and excess cash and leverage ratio management initiatives.
|
Further details of potential risks and uncertainties affecting Aegon
are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as
required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegons expectations
with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
2
Aegon (PK) (USOTC:AEGOF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Aegon (PK) (USOTC:AEGOF)
Historical Stock Chart
From Nov 2023 to Nov 2024